Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark M Moasser

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
The Biochemical Journal|August 3, 2012
HER3 signalling is regulated through a multitude of redundant mechanisms in HER2-driven tumour cellsDhara N Amin, Natalia Sergina, Lionel Lim, et al.
Scientific Reports|April 28, 2021
The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancersAvisek Majumder, Manbir Sandhu, Debarko Banerji, et al.
The American Journal of Pathology|April 8, 2009
The transmembrane src substrate Trask is an epithelial protein that signals during anchorage deprivationDanislav S Spassov, Frederick L Baehner, Ching Hang Wong, et al.
Oncogene|July 12, 2005
Adhesion signaling by a novel mitotic substrate of src kinasesAmi S Bhatt, Hediye Erdjument-Bromage, Paul Tempst, et al.
Cancer Research|May 16, 2018
HER2 Amplification in Tumors Activates PI3K/Akt Signaling Independent of HER3Ana Ruiz-Saenz, Courtney Dreyer, Marcia R Campbell, et al.
Cancer Research|December 18, 2012
Trask loss enhances tumorigenic growth by liberating integrin signaling and growth factor receptor cross-talk in unanchored cellsDanislav S Spassov, Ching Hang Wong, Sunny Y Wong, et al.
Molecular and Cellular Biology|December 30, 2010
Phosphorylation of Trask by Src kinases inhibits integrin clustering and functions in exclusion with focal adhesion signalingDanislav S Spassov, Ching Hang Wong, Natalia Sergina, et al.
Nature|January 9, 2007
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3Natalia V Sergina, Megan Rausch, Donghui Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutantsDavid R Huron, Mercedes E Gorre, Alan J Kraker, et al.
Protein Expression and Purification|October 29, 2020
Expression and purification of active human kinases using Pichia pastoris as a general-purpose hostMay H Abdel Aziz, Yao Fan, Lijun Liu, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
The Biochemical Journal|August 3, 2012
HER3 signalling is regulated through a multitude of redundant mechanisms in HER2-driven tumour cellsDhara N Amin, Natalia Sergina, Lionel Lim, et al.
Scientific Reports|April 28, 2021
The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancersAvisek Majumder, Manbir Sandhu, Debarko Banerji, et al.
The American Journal of Pathology|April 8, 2009
The transmembrane src substrate Trask is an epithelial protein that signals during anchorage deprivationDanislav S Spassov, Frederick L Baehner, Ching Hang Wong, et al.
Oncogene|July 12, 2005
Adhesion signaling by a novel mitotic substrate of src kinasesAmi S Bhatt, Hediye Erdjument-Bromage, Paul Tempst, et al.
Cancer Research|May 16, 2018
HER2 Amplification in Tumors Activates PI3K/Akt Signaling Independent of HER3Ana Ruiz-Saenz, Courtney Dreyer, Marcia R Campbell, et al.
Cancer Research|December 18, 2012
Trask loss enhances tumorigenic growth by liberating integrin signaling and growth factor receptor cross-talk in unanchored cellsDanislav S Spassov, Ching Hang Wong, Sunny Y Wong, et al.
Molecular and Cellular Biology|December 30, 2010
Phosphorylation of Trask by Src kinases inhibits integrin clustering and functions in exclusion with focal adhesion signalingDanislav S Spassov, Ching Hang Wong, Natalia Sergina, et al.
Nature|January 9, 2007
Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3Natalia V Sergina, Megan Rausch, Donghui Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutantsDavid R Huron, Mercedes E Gorre, Alan J Kraker, et al.
Protein Expression and Purification|October 29, 2020
Expression and purification of active human kinases using Pichia pastoris as a general-purpose hostMay H Abdel Aziz, Yao Fan, Lijun Liu, et al.
Pageof 6